Aesthetic Connect Public Company Limited
3.90
THB
0.00
(0.00%)
ISIN
THB640010005
Return %
Stock
S&P 500
1Y
-10.14
14.20
3Y
- -
81.12
5Y
- -
68.34
Capital Structure
THB
•
in mil. unless spec.Working Capital
THB
•
in mil. unless spec.Growth Rates
THB
•
in mil. unless spec.Quarterly Revenue
THB
•
in mil. unless spec.Quarterly Earnings Per Share
THB
•
in mil. unless spec.Quarterly Dividends Per Share
THB
•
in mil. unless spec.Company Description
- CEO
- Choladhis Sinrachtanant
- Sector
- Health services
- Industry
- Medical/Nursing services
- Address
- Bangkok Thailand
- IPO Date
- Oct 24, 2023
- Website
- teerapornclinic.com
- Similar Companies
- Business
- Aesthetic Connect Public Company Limited is a Thailand-based healthcare and medical aesthetics provider primarily engaged in delivering specialized facial plastic surgery, reconstructive procedures, aesthetic dermatology, and anti-aging wellness services under the Teeraporn brand. Founded in 2016 and tracing its clinical heritage back to 1982 through the medical practice of Asst. Prof. Dr. Choladhis Sinrachtanant, the company is headquartered in Bangkok, Thailand, and is publicly traded on the Market for Alternative Investment under the ticker symbol TRP. The company serves domestic patients across Thailand as well as international medical tourists seeking specialized facial cosmetic procedures. The company operates through integrated clinical divisions spanning surgical aesthetics, non-surgical facial rejuvenation, clinical dermatology, and preventative wellness. Its primary surgical portfolio includes proprietary short-incision facelift procedures under the Face-Lock trademark; blepharoplasty and double eyelid creation under the Eye-Lock trademark; Brow-Lock and forehead rejuvenation procedures; rhinoplasty utilizing autologous cartilage and micro-fat grafting techniques; chin augmentation and facial contouring; facial liposuction; and corrective reconstructive facial surgeries. In its non-surgical and dermatological segment, the company provides botulinum toxin injections; hyaluronic acid dermal fillers; polydioxanone thread lifting; high-intensity focused ultrasound and radiofrequency skin tightening; targeted laser therapies for pigmentation, vascular lesions, and resurfacing; chemical peels; and intravenous nutritional therapy. Through its TRP Longevity Center, the company offers preventative medicine services, including personalized hormone balancing, biomarker testing, cellular vitality therapies, and specialized medical-grade cosmeceutical skincare formulations designed for post-operative recovery and anti-aging maintenance. In recent operational developments, Aesthetic Connect has advanced a major strategic expansion by transitioning from its legacy outpatient clinic model into a comprehensive specialty hospital with the construction and commissioning of the modern Teeraporn Hospital facility located on Somdet Phra Chao Taksin Road in Bangkok. This multi-story hospital complex substantially expands surgical suite capacity, inpatient recovery amenities, and specialized consultation suites to accommodate higher case volumes and regional medical travel demand from Southeast Asia and Greater China. Following its initial public offering on the Stock Exchange of Thailand in late 2023, the company has deployed capital expenditures toward advanced operating room technologies, digital medical records systems, and the commercial rollout of its integrated longevity and wellness service lines, while forging collaborative training and research initiatives to scale its proprietary surgical methodologies across regional aesthetic healthcare markets.